Acupuncture for Chemical Therapy Induced Nausea and Vomiting: a Cross-over Trail (ACTIN)

April 14, 2016 updated by: Yutong Fei, Beijing University of Chinese Medicine
This is a randomized, controlled cross-over trial. The hypothesis of this study is that the differences in manual acupuncture manipulation can impact clinical effect though the acupuncturists follow the same needling regimen. In this study, acupuncturist 1 (clinical experience >15 years) and acupuncturist 2 (<5 years) will give treatments to cancer patients receiving cisplatin chemotherapy (n=36) for at least two continuous cycles, once per day, 5 days per cycle. Acupuncturist 1 determines all the treatment regimens (selection of acupoints and methods of needling manipulation, needle retention time). Randomly, half of the patients will receive treatments from acupuncturist 1 in the first treatment cycle and from acupuncturist 2 in the second cycle; while the other half will be treated in other way round. There is a washout period (21 days) between two cycles. The needling manipulation of two acupuncturists will be measured objectively during treatments. The clinical effect will be measured by the control of vomiting and nausea during and after chemotherapy treatments.

Study Overview

Detailed Description

This is a randomized, controlled cross-over trial. The hypothesis of this study is that the differences in manual acupuncture manipulation can impact clinical effect though the acupuncturists follow the same needling regimen. In this study, acupuncturist 1 (clinical experience >15 years) and acupuncturist 2 (<5 years) will give treatments to cancer patients receiving cisplatin chemotherapy (n=36) for at least two continuous cycles, once per day, 5 days per cycle. Acupuncturist 1 determines all the treatment regimens (selection of acupoints and methods of needling manipulation, needle retention time). Randomly, half of the patients will receive treatments from acupuncturist 1 in the first treatment cycle and from acupuncturist 2 in the second cycle; while the other half will be treated in other way round. There is a washout period (21 days) between two cycles. The needling manipulation of two acupuncturists will be measured objectively during treatments. The clinical effect will be measured by the control of vomiting and nausea during and after chemotherapy treatments. The manual manipulation of two acupuncturists will be recorded by device Acusensor.

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China, 100091
        • Xiyuan Hospital, China Academy of Chinese Medical Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Confirmed diagnosis of cancer
  • Must receive cancer chemotherapy containing cisplatin
  • Able to complete at least two continuous chemotherapy treatment cycles
  • Karnofsky performance status grade ≥60
  • Must use 5-TH receptor antagonists as an antiemetic drug in the chemotherapy duration

Exclusion Criteria:

  • Concurrent neoplasms or illness that induces nausea independent of chemotherapy
  • Receiving radiotherapy
  • Received acupuncture treatments for other conditions less than 4 weeks before chemotherapy treatment
  • Severe infection
  • Severe heart, liver, kidney and brain diseases
  • Unconsciousness
  • Psychosis
  • Language barriers
  • Cardiac pacemaker
  • Radiotherapy or hormone therapy during chemotherapy treatments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: A (Acupuncturist 1)
Manual acupuncture implemented by acupuncturist 1 (clinical experience >15 years)
Manual acupuncture once per day. Acupuncture treatment regimens (acupoints, needling methods, needle retention time) were decided by acupuncturist 1 according to the syndrome differentiation of patients. Acupuncturist 1 has to have more than 15 years of acupuncture clinical practice experience.
Other Names:
  • Traditional manual acupuncture
  • Traditional acupuncture
Active Comparator: B (Acupuncturist 2)
Manual acupuncture implemented by acupuncturist 2 (clinical experience < 5 years)
Manual acupuncture given by acupuncturist 2 once per day. Acupuncture treatment regimens (acupoints, needling methods, needle retention time) were decided by acupuncturist 1 according to the syndrome differentiation of patients. Acupuncturist 2 has to have less than 5 years of acupuncture clinical practice experience.
Other Names:
  • Traditional manual acupuncture
  • Traditional acupuncture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
NCI nausea and vomiting rating scale
Time Frame: day1-8 on each study period
day1-8 on each study period

Secondary Outcome Measures

Outcome Measure
Time Frame
Rhodes Scale
Time Frame: day1-5 on each study period
day1-5 on each study period
global assessment on effectiveness by patients (VAS)
Time Frame: day 5 on each study period
day 5 on each study period
patients' confidence towards acupuncture treatment(VAS)
Time Frame: day 1,5 on each study period
day 1,5 on each study period
global satisfaction for acupuncture treatments
Time Frame: day 5 on each study period
day 5 on each study period
Acupuncture Expectancy Scale (AES)
Time Frame: day 1, 3, 5 on each study period
day 1, 3, 5 on each study period

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient communication satisfaction scale
Time Frame: day 5 on each study period
day 5 on each study period
Acupuncture related adverse events
Time Frame: day 1-5 each study period
faintng during acupuncture treatment, sticking of needle, bleeding in the needling hole, broken needles
day 1-5 each study period
Adverse events (not acupuncture treatment specified)
Time Frame: day 1-5 each study period
day 1-5 each study period
Needling manipulation parameters
Time Frame: day 1-5 each study period
Displacement Frequency (Hz) Displacement Amplitude (pk-pk) Rotation Frequency (Hz) Rotation Amplitude (pk-pk)
day 1-5 each study period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yutong Fei, MD, Beijing University of Chinese Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

April 29, 2014

First Submitted That Met QC Criteria

April 29, 2014

First Posted (Estimate)

April 30, 2014

Study Record Updates

Last Update Posted (Estimate)

April 15, 2016

Last Update Submitted That Met QC Criteria

April 14, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EBM@BUCM-1
  • Z111107054511086 (Other Grant/Funding Number: Beijing Nova Program)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chemotherapy-induced Nausea and Vomiting

Clinical Trials on Manual acupuncture implemented by acupuncturist 1

3
Subscribe